Melanoma News and Research

Latest Melanoma News and Research

Melanoma research unveils landscape of DNA and RNA alterations across multiple organs of metastasis

In a new translational study from UCLA Jonsson Comprehensive Cancer Center, researchers analyzed genetic changes in the organs of recently deceased patients to understand how metastatic cutaneous melanoma spreads in those who had initially benefited from precision therapies.

27 Apr 2023

New class of immunotherapy shows promise against aggressive skin cancer

A new class of immunotherapy shows promising results for fighting the most aggressive form of skin cancer.

25 Apr 2023

Improving cancer treatment outcomes: the potential use of fermented food interventions

Researchers reviewed the use of fermented food interventions to alter the gut microbiome composition and improve immunotherapy.

25 Apr 2023

Maintaining normal vitamin D levels may benefit patients receiving anti-cancer immunotherapy

New research indicates that for patients with advanced skin cancer, it may be important to maintain normal vitamin D levels when receiving immunotherapy medications called immune checkpoint inhibitors.

24 Apr 2023

HPV-related cancer diagnoses more common in AYA cancer survivors

A team of researchers at Huntsman Cancer Institute and the University of Utah (the U) found that human papillomavirus-related cancer diagnoses are more common in adolescent and young adults (AYAs) who have previously had cancer.

19 Apr 2023

Researchers discover the molecule responsible for guiding T cells toward tumors

Immunotherapy, particularly CAR T-Cell treatment for cancer, is extending the lives of many patients. But sometimes the therapy randomly migrates to places it shouldn't go, tucking into the lungs or other noncancerous tissue and causing toxic side effects.

18 Apr 2023

New report provides comprehensive statistics on cancer in young Australians

This media release contains information some readers may find distressing as it refers to data about cancer incidence and deaths among adolescents and young adults.

18 Apr 2023

Experimental mRNA vaccine plus an immunotherapy reduced the likelihood of melanoma recurrence

The combination of an experimental mRNA vaccine with an immunotherapy reduced the likelihood of melanoma recurring or causing death by 44% when compared to immunotherapy alone, a new clinical trial shows.

17 Apr 2023

Many melanoma patients could avoid the risk for toxicity from combination therapies, study suggests

Data from a national clinical trial shows that a striking 89% of patients with desmoplastic melanoma responded to immunotherapy (pembrolizumab) alone, suggesting that many patients could avoid the risk for toxicity from combination therapies and achieve cancer control with this approach to treatment.

17 Apr 2023

A review of the risk factors associated with cancer evolution

Researchers reviewed existing data on tumor-promotive risk factors and their underlying mechanisms.

17 Apr 2023

Uncovering the connection between the microbiome and aging

Researchers evaluated the recent advances in understanding how the microbiome influences aging and associated diseases.

15 Apr 2023

Isolating tumor-reactive blood cells to treat cancers

Adoptive cell therapy (ACT) has become a promising immunotherapy tool to help treat advanced melanoma.

10 Apr 2023

Immunotherapy response in patients with advanced melanoma depends on prior treatments

Research led by scientists at UCLA Jonsson Comprehensive Cancer Center found that responses to a type of immunotherapy called PD-1 checkpoint blockade in patients with advanced melanoma depended on whether or not they had previously received another immunotherapy – CTLA-4 blockade – as well as other factors.

10 Apr 2023

Immune checkpoint inhibitor treatment is facilitated by dietary tryptophan metabolite synthesized by Lactobacillus reuteri

Researchers highlight how dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment.

10 Apr 2023

Improving cancer awareness among the rural American Indian communities

Phyllis Nassi, MSW, associate director of research and science, special populations, directs the American Indian program at Huntsman Cancer Institute and recently received the 2023 American Association for Cancer Research Distinguished Public Service Award for Exceptional Leadership in Cancer Advocacy.

6 Apr 2023

Phase 2 study shows safety and efficacy of new drug in men with high-risk prostate cancers

A new drug, a monoclonal antibody known as enoblituzumab, is safe in men with aggressive prostate cancer and may induce clinical activity against cancer throughout the body, according to a phase 2 study led by investigators at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy.

6 Apr 2023

Does higher caffeine and coffee intake impact colonic microbiota composition and diversity?

Researchers investigated the association between caffeine and the colonic microbiome.

6 Apr 2023

Ultra-processed food and cancer: is there a link?

Researchers performed a meta-analysis to evaluate the relationship between ultra-processed food and cancer.

5 Apr 2023

Long-term pancreatic cancer survivors’ microbiomes have increased levels of specific bacteria

Even as pancreatic cancer treatments improve, only about 9% of patients survive past five years. Researchers have searched unsuccessfully to find genetic differences that explain why some patients survive long term and some do not and have now shifted their focus to the gut microbiome.

3 Apr 2023

Researchers develop a biosensor for real time detection of the G-protein molecular switch

DGIST (President: Kook Yang) announced on March 16th that the research team led by Professor Byung-Chang Suh has investigated for the first time the real-time effect of the G-protein cycle, which acts as a switch in our body, on the structural changes in G protein-coupled receptors (GPCRs).

31 Mar 2023

Melanoma News and Research

Latest Melanoma News and Research

Melanoma research unveils landscape of DNA and RNA alterations across multiple organs of metastasis

New class of immunotherapy shows promise against aggressive skin cancer

Improving cancer treatment outcomes: the potential use of fermented food interventions

Maintaining normal vitamin D levels may benefit patients receiving anti-cancer immunotherapy

HPV-related cancer diagnoses more common in AYA cancer survivors

Researchers discover the molecule responsible for guiding T cells toward tumors

New report provides comprehensive statistics on cancer in young Australians

Experimental mRNA vaccine plus an immunotherapy reduced the likelihood of melanoma recurrence

Many melanoma patients could avoid the risk for toxicity from combination therapies, study suggests

A review of the risk factors associated with cancer evolution

Uncovering the connection between the microbiome and aging

Isolating tumor-reactive blood cells to treat cancers

Immunotherapy response in patients with advanced melanoma depends on prior treatments

Immune checkpoint inhibitor treatment is facilitated by dietary tryptophan metabolite synthesized by Lactobacillus reuteri

Improving cancer awareness among the rural American Indian communities

Phase 2 study shows safety and efficacy of new drug in men with high-risk prostate cancers

Does higher caffeine and coffee intake impact colonic microbiota composition and diversity?

Ultra-processed food and cancer: is there a link?

Long-term pancreatic cancer survivors’ microbiomes have increased levels of specific bacteria

Researchers develop a biosensor for real time detection of the G-protein molecular switch

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Melanoma News and Research

Latest Melanoma News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in